NeoPharm CO., LTD. (092730.KQ)

KRW 12830.0

(0.39%)

Eps Summary of NeoPharm CO., LTD.

NeoPharm CO., LTD.'s latest annual eps in 2023 was 1484.00 KRW , up 36.33% from previous year.
NeoPharm CO., LTD.'s latest quarterly eps in 2024 Q3 was 554.30 KRW , down -63.18% from previous quarter.
NeoPharm CO., LTD. reported an annual eps of 2177.20 KRW in 2022, down -3.87% from previous year.
NeoPharm CO., LTD. reported an annual eps of 2264.94 KRW in 2021, down -2.3% from previous year.
NeoPharm CO., LTD. reported a quarterly eps of 554.30 KRW for 2024 Q3, down -63.18% from previous quarter.
NeoPharm CO., LTD. reported a quarterly eps of 752.18 KRW for 2024 Q2, down -3.75% from previous quarter.

Annual Eps Chart of NeoPharm CO., LTD. (2023 - 2006)

Historical Annual Eps of NeoPharm CO., LTD. (2023 - 2006)

Year	Eps	Eps Growth
2023	1484.00 KRW	36.33%
2022	2177.20 KRW	-3.87%
2021	2264.94 KRW	-2.3%
2020	2318.34 KRW	-9.78%
2019	2569.66 KRW	18.28%
2018	2172.55 KRW	32.96%
2017	1633.93 KRW	49.3%
2016	1094.42 KRW	127.24%
2015	481.61 KRW	0.0%
2014	361.00 KRW	N/A
2013	258.00 KRW	N/A
2012	87.00 KRW	0.0%
2011	122.00 KRW	N/A
2010	174.00 KRW	N/A
2009	307.00 KRW	N/A
2008	505.00 KRW	N/A
2007	902.56 KRW	N/A
2006	1992.31 KRW	N/A

Year	Eps	Eps Growth
2024 Q1	781.52 KRW	1.8%
2024 Q3	554.30 KRW	-63.18%
2024 Q2	752.18 KRW	-3.75%
2023 Q1	870.59 KRW	93.2%
2023 Q4	767.68 KRW	21.75%
2023 FY	- KRW	36.33%
2023 Q2	699.34 KRW	-19.67%
2023 Q3	630.54 KRW	-9.84%
2022 Q2	588.11 KRW	-6.59%
2022 Q4	450.61 KRW	-11.45%
2022 FY	- KRW	-3.87%
2022 Q3	508.85 KRW	-13.48%
2022 Q1	629.62 KRW	3.85%
2021 Q4	606.30 KRW	52.73%
2021 Q3	396.98 KRW	-24.92%
2021 FY	- KRW	-2.3%
2021 Q2	528.71 KRW	-27.87%
2021 Q1	732.95 KRW	10.6%
2020 Q2	576.28 KRW	-15.63%
2020 FY	- KRW	-9.78%
2020 Q4	662.72 KRW	77.2%
2020 Q1	683.00 KRW	-7.56%
2020 Q3	374.00 KRW	-35.1%
2019 FY	- KRW	18.28%
2019 Q4	738.84 KRW	40.2%
2019 Q1	662.48 KRW	3.03%
2019 Q2	616.71 KRW	-6.91%
2019 Q3	527.00 KRW	-14.55%
2018 Q1	601.94 KRW	52.61%
2018 FY	- KRW	32.96%
2018 Q3	396.00 KRW	-22.2%
2018 Q2	508.98 KRW	-15.44%
2018 Q4	643.00 KRW	62.37%
2017 Q1	472.94 KRW	12.87%
2017 FY	- KRW	49.3%
2017 Q2	432.15 KRW	-8.62%
2017 Q3	318.00 KRW	-26.41%
2017 Q4	394.42 KRW	24.03%
2016 Q3	251.00 KRW	111.69%
2016 FY	- KRW	127.24%
2016 Q2	118.57 KRW	-72.04%
2016 Q4	419.00 KRW	66.93%
2016 Q1	424.00 KRW	578.23%
2015 Q2	117.00 KRW	0.0%
2015 FY	- KRW	0.0%
2015 Q3	179.00 KRW	52.99%
2015 Q4	-88.66 KRW	-149.53%
2013 Q2	154.00 KRW	25.2%
2013 Q1	123.00 KRW	1777.86%
2013 Q3	-86.00 KRW	-155.84%
2012 Q4	6.55 KRW	0.0%
2012 FY	- KRW	0.0%

Peer Eps Comparison of NeoPharm CO., LTD.

Name	Eps	Eps Difference
Kolmar BNH Co., Ltd.	674.49 KRW	-120.018%